• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2004 Fiscal Year Final Research Report Summary

Growth regulation mediated by EGF family of growth factors

Research Project

Project/Area Number 14032202
Research Category

Grant-in-Aid for Scientific Research on Priority Areas

Allocation TypeSingle-year Grants
Review Section Biological Sciences
Research InstitutionOsaka University

Principal Investigator

MEKADA Eisuke  Osaka University, Research Institute for Microbial Diseases, Professor, 微生物病研究所, 教授 (20135742)

Co-Investigator(Kenkyū-buntansha) WAMOTO Ryoi  Osaka University, Research Institute for Microbial Diseases, Assiociate Professor, 微生物病研究所, 助教授 (10213323)
Project Period (FY) 2002 – 2004
KeywordsHB-EGF / EGF family / growth factor / ovarian cancer / diphtheria toxin
Research Abstract

HB-EGF is a member of the EGF family growth factors. This factor is synthesized as proHB-EGF, a membrane-anchored precursor protein, and is cleaved on the cell surface to yield the soluble growth factor. The conversion of proHB-EGF into the soluble form is critical for the activity of this growth factor, and therefore this process is tightly regulated. We found that, among the EGFR family of growth factors, HB-EGF gene expression in cancerous tissues of ovarian cancer and HB-EGF protein levels in patients' ascites fluid were significantly elevated. The human ovarian cancer cell lines SKOV3 and RMG-1 form tumors in nude mice. Tumor formation of these cells was enhanced by exogenous expression of proHB-EGF, and completely blocked by proHB-EGF gene RNA interference or by CRM197, a specific HB-EGF inhibitor. Transfection with mutant forms of HB-EGF indicated that the release of soluble HB-EGF is essential for tumor formation. These results indicate that HB-EGF is the primary member of the EGFR family of growth factors expressed in ovarian cancer and that LPA-induced ectodomain shedding of this growth factor is a critical step in tumor formation, making HB-EGF a novel therapeutic target for ovarian cancer.

  • Research Products

    (10 results)

All 2004 2003 2002

All Journal Article (10 results)

  • [Journal Article] Heparin-binding EGF-like growth factor and the LPA-induced ectodomain shedding pathway is a promising target for the therapy of ovarian cancer.2004

    • Author(s)
      Miyamoto, S., et al.
    • Journal Title

      Cancer Res. 64

      Pages: 5720-5727

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] HB-EGF and ErbB signaling is essential for heart function.2003

    • Author(s)
      Iwamoto, R., et al.
    • Journal Title

      Proc. Natl. Acad. Sci. U.S.A. 100

      Pages: 3221-3225

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] The stree- and the inflammatory cytokine-induced ectodomain shedding of heparin-binding EGF-like growth factor is mediated by p38 MAPK, distinct from TPA-induced and LPA-induced signaling cascades.2003

    • Author(s)
      Takenobu, H., et al.
    • Journal Title

      J. Biol. Chem. 278

      Pages: 17255-17262

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.2003

    • Author(s)
      Takeda, Y., et al.
    • Journal Title

      J. Cell. Biol. 161

      Pages: 945-956

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities.2003

    • Author(s)
      Yamazaki, S., et al.
    • Journal Title

      J. Cell. Biol. 163

      Pages: 469-475

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] The stress-and the inflammatory cytokine-induced ectodomain shedding of heparin-binding EGF-like growth factor is mediated by p38 MAPK, distinct from TPA-induced and LPA-induced signaling cascade.2003

    • Author(s)
      Takenobu, H., et al.
    • Journal Title

      J. Biol. Chem. 278

      Pages: 17255-17262

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.2003

    • Author(s)
      Takeda, Y., et al.
    • Journal Title

      J. Cell Biol. 161

      Pages: 945-956

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities.2003

    • Author(s)
      Yamazaki, S., et al.
    • Journal Title

      J. Cell Biol. 163

      Pages: 469-475

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Ligand-independent dimer formation of EGFR is a step separable from ligand-iniduced EGFR signaling.2002

    • Author(s)
      Yu, X., et al.
    • Journal Title

      Mol. Biol. Cell 13

      Pages: 2547-2557

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Ligand-independent dimer formation of EGFR is a step separable from ligand-induced EGFR signaling.2002

    • Author(s)
      Yu, X., et al.
    • Journal Title

      Mol. Biol. Cell 13

      Pages: 2547-2557

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2008-05-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi